References of "Lancellotti, Patrizio"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailResearch and innovations committee a new outlook for the European Association of Cardiovascular Imaging (EACVI).
Donal, Erwan; Badano, Luigi; Habib, Gilbert et al

in European Heart Journal - Cardiovascular Imaging (2013), 14(4), 400

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailThe year 2012 in the European Heart Journal - Cardiovascular Imaging: Part I.
Edvardsen, Thor; Plein, Sven; Saraste, Antti et al

in European Heart Journal - Cardiovascular Imaging (2013), 14(6), 509-14

The new multi-modality cardiovascular imaging journal, European Heart Journal - Cardiovascular Imaging, was started in 2012. During its first year, the new Journal has published an impressive collection ... [more ▼]

The new multi-modality cardiovascular imaging journal, European Heart Journal - Cardiovascular Imaging, was started in 2012. During its first year, the new Journal has published an impressive collection of cardiovascular studies utilizing all cardiovascular imaging modalities. We will summarize the most important studies from its first year in two articles. The present 'Part I' of the review will focus on studies in myocardial function, myocardial ischaemia, and emerging techniques in cardiovascular imaging. [less ▲]

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailDrug-induced valvular heart disease.
Cosyns, Bernard; Droogmans, Steven; Rosenhek, Raphael et al

in Heart (British Cardiac Society) (2013), 99(1), 7-12

Drug-induced valvular heart disease (DIVHD) was first described in the 1960s. Initially, associations with ergot derivatives used for migraine prevention, or with anorectic drugs, were described. Drugs ... [more ▼]

Drug-induced valvular heart disease (DIVHD) was first described in the 1960s. Initially, associations with ergot derivatives used for migraine prevention, or with anorectic drugs, were described. Drugs used for the treatment of Parkinson's disease and endocrine diseases, like hyperprolactinemia, may also induce VHD. More recently, the use of 3,4-methylendioxymetamphetamine (MDMA, 'Ecstasy') and benfluorexhave been found to be associated with DIVHD. Although some of these drugs were withdrawn from the market, several cases of patients requiring valve surgery even years after the cessation of therapy have been reported. DIVHD is not infrequent, may be severe, and has been described in association with several drugs. Even after drug cessation, long-term implications of this type of VHD may persist. The present review underlines the need for a careful evaluation of the associated clinical and echocardiographic risk factors to allow early recognition so as not to delay appropriate management. [less ▲]

Detailed reference viewed: 23 (4 ULg)
Full Text
Peer Reviewed
See detailPractical recommendations on the use of echocardiography to assess pulmonary arterial hypertension--a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging.
LANCELLOTTI, Patrizio ULg; Budts, Werner; de Wolf, Daniel et al

in Acta Cardiologica (2013), 68(1), 59-69

Pulmonary hypertension (PH) is defined by a sustained increase in mean pulmonary arterial pressure > 25 mmHg. Due to its widespread availability, echocardiography (ECHO) is used as the first-line imaging ... [more ▼]

Pulmonary hypertension (PH) is defined by a sustained increase in mean pulmonary arterial pressure > 25 mmHg. Due to its widespread availability, echocardiography (ECHO) is used as the first-line imaging modality to detect pulmonary PH and assess right ventricular (RV) function in daily routine. As such, ECHO is the key examination to detect the presence of PH, to provide valuable prognostic information and to give an orientation to therapeutic strategies. In addition to detection and screening, ECHO also provides clues for the differential diagnosis of PH. The present document, based on a consensus of experts, provides practical recommendations for the use of ECHO in the evaluation of PH and of its consequences on the right ventricle. [less ▲]

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailDefinition of moderate ischemic mitral regurgitation: it's time to speak the same language.
Fattouch, K.; Punjabi, P.; LANCELLOTTI, Patrizio ULg

in Perfusion (2013), 28(2), 173-5

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailOutcome in Aortic Stenosis: When the Flow Makes the Difference.
LANCELLOTTI, Patrizio ULg; Dulgheru, Raluca

in Revista Espanola de Cardiologia (2013), 66(4), 248-250

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailMitral regurgitation after transcatheter aortic valve replacement: Does the prosthesis matter?
Unger, Philippe; Dedobbeleer, Chantal; Vanden Eynden, Frederic et al

in International Journal of Cardiology (2013)

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailThe use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology.
Blomstrom Lundqvist, Carina; Auricchio, Angelo; Brugada, Josep et al

in Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology (2013)

Implantations of cardiac devices therapies and ablation procedures frequently depend on accurate and reliable imaging modalities for pre-procedural assessments, intra-procedural guidance, detection of ... [more ▼]

Implantations of cardiac devices therapies and ablation procedures frequently depend on accurate and reliable imaging modalities for pre-procedural assessments, intra-procedural guidance, detection of complications, and the follow-up of patients. An understanding of echocardiography, cardiovascular magnetic resonance imaging, nuclear cardiology, X-ray computed tomography, positron emission tomography, and vascular ultrasound is indispensable for cardiologists, electrophysiologists as well as radiologists, and it is currently recommended that physicians should be trained in several imaging modalities. There are, however, no current guidelines or recommendations by electrophysiologists, cardiac imaging specialists, and radiologists, on the appropriate use of cardiovascular imaging for selected patient indications, which needs to be addressed. A Policy Conference on the use of imaging in electrophysiology and device management, with representatives from different expert areas of radiology and electrophysiology and commercial developers of imaging and device technologies, was therefore jointly organized by European Heart Rhythm Association (EHRA), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology (ESCR). The objectives were to assess the state of the level of evidence and a first step towards a consensus document for currently employed imaging techniques to guide future clinical use, to elucidate the issue of reimbursement structures and health economy, and finally to define the need for appropriate educational programmes to ensure clinical competence for electrophysiologists, imaging specialists, and radiologists. [less ▲]

Detailed reference viewed: 13 (1 ULg)
Full Text
See detailA prospective study of cardiac valvular status in patients treated with cabergoline for endocrine disease
VROONEN, Laurent ULg; LANCELLOTTI, Patrizio ULg; Tome, M et al

in Symposium "Perspectives in Endocrinology" - Congresses Highlights 2012: ECE Firenze, ENDO Houston, ESPE Leipzig, SFE Toulouse, IWMEN Liège (2013)

Detailed reference viewed: 28 (4 ULg)
Full Text
Peer Reviewed
See detailEchocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats.
Roosens, Bram; Bala, Gezim; Gillis, Kris et al

in Cardiovascular Ultrasound (2013), 11(1), 4

ABSTRACT: BACKGROUND: Calcification is an independent predictor of mortality in calcific aortic valve disease (CAVD). The aim of this study was to evaluate the use of non-invasive, non-ionizing ... [more ▼]

ABSTRACT: BACKGROUND: Calcification is an independent predictor of mortality in calcific aortic valve disease (CAVD). The aim of this study was to evaluate the use of non-invasive, non-ionizing echocardiographic calibrated integrated backscatter (cIB) for monitoring progression and subsequent regression of aortic valvular calcifications in a rat model of reversible renal failure with CAVD, compared to histology. METHODS: 28 male Wistar rats were prospectively followed during 21 weeks. Group 1 (N=14) was fed with a 0.5% adenine diet for 9 weeks to induce renal failure and CAVD. Group 2 (N=14) received a standard diet. At week 9, six animals of each group were killed. The remaining animals of group 1 (N=8) and group 2 (N=8) were kept on a standard diet for an additional 12 weeks. cIB of the aortic valve was calculated at baseline, 9 and 21 weeks, followed by measurement of the calcified area (Ca Area) on histology. RESULTS: At week 9, cIB values and Ca Area of the aortic valve were significantly increased in the adenine-fed rats compared to baseline and controls. After 12 weeks of adenine diet cessation, cIB values and Ca Area of group 1 decreased compared to week 9, while there was no longer a significant difference compared to age-matched controls of group 2. CONCLUSIONS: cIB is a non-invasive tool allowing quantitative monitoring of CAVD progression and regression in a rat model of reversible renal failure, as validated by comparison with histology. This technique might become useful for assessing CAVD during targeted therapy. [less ▲]

Detailed reference viewed: 20 (6 ULg)
Full Text
Peer Reviewed
See detailEuroEcho and other imaging modalities: highlights
LANCELLOTTI, Patrizio ULg; Magne, Julien ULg; Sicari, R et al

in European Journal of Echocardiography (2013)

Detailed reference viewed: 20 (2 ULg)
Full Text
Peer Reviewed
See detailImpact of hemodynamic load on exercise capacity in aortic stenosis
Dulgheru, Raluca Elena ULg; Magne, Julien ULg; Capoulade, R et al

in International Journal of Cardiology (2013)

Detailed reference viewed: 87 (6 ULg)
Full Text
Peer Reviewed
See detailLeft ventricular contractile reserve in asymptomatic primary mitral regurgitation
Magne, Julien ULg; Mahjoub, H; PIERARD, Luc ULg et al

in European Heart Journal (2013)

Detailed reference viewed: 28 (6 ULg)
Full Text
Peer Reviewed
See detailnon invasive estimation of left atrial pressure and mitral valve area waveforms during an entire cardiac cycle
Paeme, Sabine ULg; Pironet, Antoine ULg; LANCELLOTTI, Patrizio ULg et al

in proceeding of 11th national day of the National Committee on Biomedical Engineering (2012, December 07)

Detailed reference viewed: 20 (3 ULg)
Full Text
Peer Reviewed
See detailStructural model of the mitral valve included in a cardiovascular closed loop model. Static and dynamic validation
Paeme, Sabine ULg; Pironet, Antoine ULg; Chase, J. Geoffrey et al

in proceedings of 8th IFAC Symposium on Biological and Medical Systems, Budapest 29-31 août 2012 (2012, August 31)

Detailed reference viewed: 23 (4 ULg)
Full Text
Peer Reviewed
See detailPapillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation.
Fattouch, K.; Lancellotti, Patrizio ULg; Castrovinci, S. et al

in Journal of Thoracic and Cardiovascular Surgery (The) (2012), 143(6), 1352-5

OBJECTIVE: the incidence of recurrent mitral regurgitation (MR) after restrictive annuloplasty (RA) was 5% to 20% in several reports. There are many opinions in favor of adding subvalvular procedures to ... [more ▼]

OBJECTIVE: the incidence of recurrent mitral regurgitation (MR) after restrictive annuloplasty (RA) was 5% to 20% in several reports. There are many opinions in favor of adding subvalvular procedures to RA to reduce the tenting forces and improve the repair results. METHODS: From March 2003 to May 2010, 55 patients with severe ischemic MR who had undergone papillary muscle (PPM) relocation in conjunction with mitral annuloplasty in our institutions were enrolled. The patients were matched 1:1 with those who underwent isolated RA using the propensity score. The mean left ventricular ejection fraction was 42% ± 6%. The mean tenting area and coaptation depth was 3.2 ± 0.6 cm(2) and 1.3 ± 0.2 cm, respectively. The study endpoints were early mortality and clinical and echocardiographic outcomes, freedom from cardiac-related deaths, and cardiac-related events. RESULTS: In-hospital death occurred in 5 patients (4.5%), without a statistically significant difference between the 2 groups (P = .72). The 5-year freedom from cardiac-related deaths and cardiac-related events in the PPM relocation group versus the RA group was 90.9% ± 1.8% versus 89% ± 1.6% (P = .82) and 83% ± 2.1% versus 65.4% ± 1.2% (P < .001), respectively. Recurrent MR equal to or greater than moderate occurred in 2 (3.7%) and 6 (11.5%) patients in the PPM relocation group and RA group (P = .01), respectively. Moreover, we found statistically significant differences for the postoperative mean tenting area and coaptation depth in both groups (P < .001). CONCLUSIONS: PPM relocation in conjunction to mitral annuloplasty is an easy and safe method and can be performed without an increase in-hospital mortality. This technique reduced the tenting area and coaptation depth compared with isolated RA, leading to improvement in the incidence of recurrent MR. The PPM group of patients experienced fewer cardiac-related events. [less ▲]

Detailed reference viewed: 14 (2 ULg)